𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer

✍ Scribed by F. Pannuti; A. Martoni; A.R. Di Marco; E. Piana; F. Saccani; G. Becchi; G. Mattioli; F. Barbanti; G.A. Marra; W. Persiani; L. Cacciari; F. Spagnolo; D. Palenzona; G. Rocchetta


Book ID
113146256
Publisher
Elsevier Science
Year
1979
Weight
633 KB
Volume
15
Category
Article
ISSN
0014-2964

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical trial of high-dose oral medroxy
✍ Enrique Davila; Charles L. Vogel; Dawn East; Victoria Cairns; Susan Hilsenbeck πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 696 KB

Recent studies have suggested that there are benefits from the use of high-dose parenteral medroxyprogesterone acetate (MPA) in the treatment of metastatic breast cancer. The present study was designed to assess the efficacy and toxicity of high-dose oral MPA in women with clinical parameters sugges